Sichuan Hebang Biotechnology Corporation Limited (SHA:603077)
China flag China · Delayed Price · Currency is CNY
1.770
+0.020 (1.14%)
May 16, 2025, 3:00 PM CST

SHA:603077 Statistics

Total Valuation

SHA:603077 has a market cap or net worth of CNY 14.11 billion. The enterprise value is 16.25 billion.

Market Cap 14.11B
Enterprise Value 16.25B

Important Dates

The last earnings date was Tuesday, April 29, 2025.

Earnings Date Apr 29, 2025
Ex-Dividend Date n/a

Share Statistics

SHA:603077 has 7.97 billion shares outstanding. The number of shares has increased by 5.20% in one year.

Current Share Class 7.97B
Shares Outstanding 7.97B
Shares Change (YoY) +5.20%
Shares Change (QoQ) +24.98%
Owned by Insiders (%) 6.00%
Owned by Institutions (%) 3.21%
Float 4.90B

Valuation Ratios

The trailing PE ratio is 994.63.

PE Ratio 994.63
Forward PE n/a
PS Ratio 1.71
PB Ratio 0.75
P/TBV Ratio 1.01
P/FCF Ratio n/a
P/OCF Ratio 16.67
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.48, with an EV/FCF ratio of -40.78.

EV / Earnings 1,144.95
EV / Sales 1.96
EV / EBITDA 17.48
EV / EBIT n/a
EV / FCF -40.78

Financial Position

The company has a current ratio of 2.82, with a Debt / Equity ratio of 0.48.

Current Ratio 2.82
Quick Ratio 1.79
Debt / Equity 0.48
Debt / EBITDA 9.68
Debt / FCF -22.58
Interest Coverage -0.69

Financial Efficiency

Return on equity (ROE) is -0.47% and return on invested capital (ROIC) is -0.13%.

Return on Equity (ROE) -0.47%
Return on Assets (ROA) -0.12%
Return on Invested Capital (ROIC) -0.13%
Return on Capital Employed (ROCE) -0.22%
Revenue Per Employee 1.15M
Profits Per Employee 1,979
Employee Count 7,169
Asset Turnover 0.30
Inventory Turnover 1.60

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -13.73% in the last 52 weeks. The beta is 0.36, so SHA:603077's price volatility has been lower than the market average.

Beta (5Y) 0.36
52-Week Price Change -13.73%
50-Day Moving Average 1.78
200-Day Moving Average 1.88
Relative Strength Index (RSI) 56.33
Average Volume (20 Days) 53,998,278

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, SHA:603077 had revenue of CNY 8.27 billion and earned 14.19 million in profits. Earnings per share was 0.00.

Revenue 8.27B
Gross Profit 519.76M
Operating Income -53.91M
Pretax Income -88.65M
Net Income 14.19M
EBITDA 917.39M
EBIT -53.91M
Earnings Per Share (EPS) 0.00
Full Income Statement

Balance Sheet

The company has 7.12 billion in cash and 9.00 billion in debt, giving a net cash position of -1.88 billion or -0.24 per share.

Cash & Cash Equivalents 7.12B
Total Debt 9.00B
Net Cash -1.88B
Net Cash Per Share -0.24
Equity (Book Value) 18.73B
Book Value Per Share 2.32
Working Capital 8.95B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 846.71 million and capital expenditures -1.25 billion, giving a free cash flow of -398.40 million.

Operating Cash Flow 846.71M
Capital Expenditures -1.25B
Free Cash Flow -398.40M
FCF Per Share -0.05
Full Cash Flow Statement

Margins

Gross margin is 6.28%, with operating and profit margins of -0.65% and 0.17%.

Gross Margin 6.28%
Operating Margin -0.65%
Pretax Margin -1.07%
Profit Margin 0.17%
EBITDA Margin 11.09%
EBIT Margin -0.65%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 1.14%.

Dividend Per Share 0.02
Dividend Yield 1.14%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 1,835.57%
Buyback Yield -5.20%
Shareholder Yield -4.06%
Earnings Yield 0.10%
FCF Yield -2.82%
Dividend Details

Stock Splits

The last stock split was on July 5, 2017. It was a forward split with a ratio of 2.2.

Last Split Date Jul 5, 2017
Split Type Forward
Split Ratio 2.2

Scores

SHA:603077 has an Altman Z-Score of 1.95. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.95
Piotroski F-Score n/a